everseen

About everseen

Eversense is a leading innovator in the healthcare technology sector, specializing in advanced continuous glucose monitoring (CGM) systems. Headquartered in the United States, the company has established itself as a pioneer in diabetes management solutions, leveraging cutting-edge technology to improve patient outcomes. Founded with a mission to transform diabetes care, Eversense provides reliable, long-term monitoring solutions that empower individuals to take control of their health with confidence. The company’s flagship product is the Eversense CGM system, a fully implantable device that offers up to 90 days of continuous glucose data without the need for frequent sensor changes. Key features include real-time alerts for high and low glucose levels, customizable alarms, and seamless integration with smartphones and healthcare provider platforms. Targeted primarily at individuals with diabetes, healthcare professionals, and caregivers, the system is designed to enhance daily management, reduce the burden of diabetes, and support informed clinical decisions. Eversense has gained significant recognition for its commitment to innovation and patient-centric design, holding multiple FDA approvals and CE Mark certifications. The company’s market position is strengthened by its focus on accuracy, convenience, and long-term usability, setting it apart from traditional CGM systems. By combining advanced technology with a deep understanding of patient needs, Eversense continues to lead the way in improving the quality of life for those living with diabetes.